Cargando…

Global Increase in Circular RNA Levels in Myotonic Dystrophy

Splicing aberrations induced as a consequence of the sequestration of muscleblind-like splicing factors on the dystrophia myotonica protein kinase transcript, which contains expanded CUG repeats, present a major pathomechanism of myotonic dystrophy type 1 (DM1). As muscleblind-like factors may also...

Descripción completa

Detalles Bibliográficos
Autores principales:	Czubak, Karol, Taylor, Katarzyna, Piasecka, Agnieszka, Sobczak, Krzysztof, Kozlowska, Katarzyna, Philips, Anna, Sedehizadeh, Saam, Brook, J. David, Wojciechowska, Marzena, Kozlowski, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689976/ https://www.ncbi.nlm.nih.gov/pubmed/31428124 http://dx.doi.org/10.3389/fgene.2019.00649

Ejemplares similares

An Overview of Circular RNAs and Their Implications in Myotonic Dystrophy
por: Czubak, Karol, et al.
Publicado: (2019)

Quantitative Methods to Monitor RNA Biomarkers in Myotonic Dystrophy
por: Wojciechowska, Marzena, et al.
Publicado: (2018)

Differential fates of introns in gene expression due to global alternative splicing
por: Kumari, Anjani, et al.
Publicado: (2021)

Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1
por: Wojciechowska, Marzena, et al.
Publicado: (2014)

Oncogenomic portals for the visualization and analysis of genome-wide cancer data
por: Klonowska, Katarzyna, et al.
Publicado: (2015)

Small Molecules Which Improve Pathogenesis of Myotonic Dystrophy Type 1
por: López-Morató, Marta, et al.
Publicado: (2018)

Oral administration of erythromycin decreases RNA toxicity in myotonic dystrophy
por: Nakamori, Masayuki, et al.
Publicado: (2015)

Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy
por: Wojtkowiak-Szlachcic, Agnieszka, et al.
Publicado: (2015)

Regulatory Potential of Competing Endogenous RNAs in Myotonic Dystrophies
por: Koscianska, Edyta, et al.
Publicado: (2021)

A Medley of Malnutrition and Myotonic Dystrophy: Twice Unlucky
por: Malik, Hajira Z, et al.
Publicado: (2022)

Sustainable recovery of MBNL activity in autoregulatory feedback loop in myotonic dystrophy
por: Rogalska, Zuzanna, et al.
Publicado: (2022)

CAG repeats mimic CUG repeats in the misregulation of alternative splicing
por: Mykowska, Agnieszka, et al.
Publicado: (2011)

Autistic traits in myotonic dystrophy type 1 due to MBNL inhibition and RNA mis-splicing
por: Sznajder, Lukasz, et al.
Publicado: (2023)

Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1
por: Voellenkle, Christine, et al.
Publicado: (2019)

High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer
por: Czubak, Karol, et al.
Publicado: (2015)

Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
por: Krzyzosiak, Wlodzimierz J., et al.
Publicado: (2012)

Identification of DAPK1 as an autophagy-related biomarker for myotonic dystrophy type 1
por: Hu, Min, et al.
Publicado: (2022)

Disrupting the Molecular Pathway in Myotonic Dystrophy
por: Xing, Xiaomeng, et al.
Publicado: (2021)

The Use of a Two-Tiered Testing Strategy for the Simultaneous Detection of Small EGFR Mutations and EGFR Amplification in Lung Cancer
por: Lewandowska, Marzena Anna, et al.
Publicado: (2015)

Expanded CUG Repeat RNA Induces Premature Senescence in Myotonic Dystrophy Model Cells
por: Hasuike, Yuhei, et al.
Publicado: (2022)

Myotonic dystrophy
por: Patterson, VH
Publicado: (1990)

The 30 kb deletion in the APOBEC3 cluster decreases APOBEC3A and APOBEC3B expression and creates a transcriptionally active hybrid gene but does not associate with breast cancer in the European population
por: Klonowska, Katarzyna, et al.
Publicado: (2017)

AON-induced splice-switching and DMPK pre-mRNA degradation as potential therapeutic approaches for Myotonic Dystrophy type 1
por: Stepniak-Konieczna, Ewa, et al.
Publicado: (2020)

Repeat Interruptions Modify Age at Onset in Myotonic Dystrophy Type 1 by Stabilizing DMPK Expansions in Somatic Cells
por: Pešović, Jovan, et al.
Publicado: (2018)

Cancer and Myotonic Dystrophy
por: D’Ambrosio, Eleonora S., et al.
Publicado: (2023)

A CRISPR-Cas13a Based Strategy That Tracks and Degrades Toxic RNA in Myotonic Dystrophy Type 1
por: Zhang, Nan, et al.
Publicado: (2020)

Desflurane anaesthesia in myotonic dystrophy
por: Gandhi, Ranju, et al.
Publicado: (2011)

Myotonic Dystrophy: An Anaesthetic Dilemma
por: Gupta, N, et al.
Publicado: (2009)

Cardiac involvement in myotonic dystrophy
por: Khalighi, Koroush, et al.
Publicado: (2015)

Steakhouse Syndrome in Myotonic Dystrophy
por: Ogasawara, Nobuhiko, et al.
Publicado: (2017)

Cutaneous findings in myotonic dystrophy
por: Kong, Ha Eun, et al.
Publicado: (2022)

Marathoning with myotonic dystrophy type 2 (proximal myotonic myopathy) and leukopenia
por: Finsterer, Josef, et al.
Publicado: (2017)

Zebrafish deficient for Muscleblind-like 2 exhibit features of myotonic dystrophy
por: Machuca-Tzili, Laura E., et al.
Publicado: (2011)

Respiratory failure in myotonic dystrophy 1
Publicado: (2013)

Multidimensional aspects of pain in myotonic dystrophies
por: Peric, Marina, et al.
Publicado: (2015)

Myotonic Dystrophy—A Progeroid Disease?
por: Meinke, Peter, et al.
Publicado: (2018)

Hyperostosis Frontalis Interna in Myotonic Dystrophy
por: Suzuki, Keisuke, et al.
Publicado: (2017)

Core Clinical Phenotypes in Myotonic Dystrophies
por: Wenninger, Stephan, et al.
Publicado: (2018)

Achalasia in a Patient with Myotonic Dystrophy
por: Sato, Hiroki, et al.
Publicado: (2019)

Epigenetics of Myotonic Dystrophies: A Minireview
por: Visconti, Virginia Veronica, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rmtube0a3ra9frtcnodikmpl1e